3TC: now available again up to CD4 of 300.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy* / Q000276:immunology; D018791:CD4 Lymphocyte Count / Q000187:drug effects; D004345:Drug Industry; D004359:Drug Therapy, Combination; D006801:Humans; D019259:Lamivudine; D018579:Patient Selection; D014481:United States; D016047:Zalcitabine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000600:supply & distribution / Q000627:therapeutic use*; D015215:Zidovudine / Q000008:administration & dosage
D019259:Lamivudine; D015215:Zidovudine; D016047:Zalcitabine